Hospital Antibiotics May Increase C. Diff Infection Risk For Next Patient in Same Bed: Study

New research warns that patients may be more likely to get a hospital-acquired infection if they are in a bed that was last used by another patient who was treated with antibiotics. 

In a study published in the Journal of the American Medical Association (JAMA) on October 10, researchers found that patients occupying the same bed space following a prior patient’s receipt of antibiotics were more likely to subsequently contract clostridium difficile colitis (CDI), also known as c. diff, which is a serious infection that causes inflammation of the colon.

Researchers set out to examine how one patients receipt of antibiotics may impact surrounding non-antibiotic treated patients, and if the risk of infections increased. Lead author, Daniel Freedberg, MD, MS, Division of Digestive and Liver Disease of the Columbia University Medical Center, designed the study to identify the potential alteration of local microenvironments that may affect patients’ risk for c. diff infections.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

The retrospective cohort study used data from adult patients hospitalized in four New York facilities between 2010 and 2015. Researchers used electronic time stamps to identify sequential patients who occupied given hospital beds, under the criteria that patients spent at least 24 hours within the facility and were not diagnosed with c. diff before entering.

Freedberg’s research team collected data on 100,615 pairs of patients who sequentially occupied a given hospital bed within the four hospitals and found 576 pairs in which subsequent patients developed clostridium difficile colitis. After assessing various additional risk factors that could have contributed to clostridium difficile colitis infections, researchers found a 22% relative increase in risk for infections in subsequent patients who occupied the same bed as those that received antibiotic treatments.

Widespread use of antibiotics in hospitals has become a growing concern, due to the long established evidence that antibiotic prescription in hospital settings is a crucial risk factor for clostridium difficile colitis infection outbreaks. Several studies have shown antibiotics are over and unnecessarily prescribed, increasing individual risk for clostridium difficile colitis.

In a study published by JAMA in May this year, researchers found antibiotics were prescribed unnecessarily 30% of the time. This included prescriptions that were given to treat viral infections and prescriptions that were given for the incorrect length of time.

Using antibiotics inappropriately contributes to the emergence of resistant strains of bacteria, making it more difficult to treat infections. Research published in March by the U.S. Centers for Disease Control and Prevention indicates one-in-seven hospital acquired infections are now antibiotic resistant, focusing scrutiny on the way doctors treat antibiotic resistant infections, especially with unnecessary rounds of antibiotics.

Other research indicates more than 23,000 Americans die each year from antibiotic resistant bacteria and 2 million become sick due to the so called superbugs every year.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.